Cardiac Monitoring & Cardiac Rhythm Management Devices Market

Report Code MD 1038
Published in May, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size, Share & Trends by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) & Region - Global Forecast to 2029

Overview

The global cardiac monitoring & cardiac rhythm management devices market, valued at US$20.7 billion in 2023, is forecasted to grow at a robust CAGR of 4.3%, reaching US$21.3 billion in 2024 and an impressive US$26.4 billion by 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics. The expansion of this market is majorly due to presence of Favorable regulatory frameworks and reimbursement policies for cardiac monitoring and rhythm management devices incentivize healthcare providers to invest in these technologies and integrate them into clinical practice. However, Integration and interoperability issues between different cardiac monitoring devices and electronic health record systems may hinder seamless data exchange and care coordination.

Attractive Opportunities in the Cardiac Monitoring & Cardiac Rhythm Management Devices Market

ASIA PACIFIC:

Market growth in the Asia Pacific can be attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking, and rising morbidity and mortality from CVD.

Increasing emphasis on early disease detection and prevention The increasing prevalence of geriatric population Increasing investments, funds, and grants for research.

Measures to reduce infections caused by CIEDs and Untapped emerging markets are factors expected to provide lucrative opportunities for market players.

The European cardiac monitoring & cardiac rhythm management devices is expected to be worth USD 7797 million by 2029, growing at CAGR of 3.8% during the forecast period.

Frequent product recalls and Stringent regulatory requirements delaying the approval of cardiac devices are restraints of this market.

Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Dynamics

DRIVER: Growing Geriatric Population and Subsequent Increase In CVD Prevalence

The global population is aging, with a significant portion of the population being aged 65 and above. Elderly individuals are more prone to developing cardiovascular diseases due to factors such as age-related changes in the cardiovascular system, comorbidities, and lifestyle factors. Likewise, Aging is associated with an increased risk of cardiovascular diseases such as coronary artery disease, heart failure, atrial fibrillation, and arrhythmias. As the geriatric population grows, so does the prevalence of these cardiovascular conditions, driving the demand for cardiac monitoring and rhythm management devices.The geriatric population is at a higher risk of CVDs, lung diseases, stroke, diabetes, and chronic kidney disease. Most of these diseases require the continuous monitoring of vital signs, such as blood pressure, temperature, respiratory rate, and heart rate and rhythm. Considering this, cardiac monitoring devices, with other parameters (such as blood pressure and pulse rate), are rapidly being adopted globally for personal and hospital care.Per a UN report, the global population aged 60 years and above was 761 million in 2021 and is expected to rise to 1.6 billion in 2050. According to World Population Prospects (2019 Revision), by 2050, one in four persons residing in Europe and Northern America could be 65 years or above. Furthermore, according to the American Heart Association (AHA) 2020, the geriatric population in the US (individuals aged 65 and over) increased from 40 million in 2007 to 51 million in 2017; this is projected to reach 95 million in 2060. Given this dramatic growth in the aged population, age-related heart failure (HF) is expected to increase significantly.The expanding population base of geriatric patients and the rising prevalence rate of various CVDs are expected to drive market growth in the coming years.

RESTRAINT: High device cost

The high cost of CM & CRM devices is a major factor restraining market growth, especially in developing countries with inadequate reimbursement policies. Pacemaker implantation surgery in India costs a fraction of the same in the US and other developed countries. The average cost of pacemaker implantation surgery in India is USD 3,000 to USD 5,500. The high cost of cardiac monitoring and rhythm management devices can impose a significant financial burden on patients, especially those with limited financial resources or inadequate insurance coverage. Patients may hesitate to invest in expensive devices, leading to delayed or deferred treatment and monitoring, which can negatively impact their health outcomes.S imilarly, The high device cost can create affordability barriers for patients who require ongoing monitoring and management of cardiovascular conditions, such as heart failure, arrhythmias, and coronary artery disease. Patients may forego recommended cardiac monitoring or opt for less expensive alternatives, compromising the quality and effectiveness of their care.

 

OPPORTUNITY: Wearable Technologies and Mobile Health (MHealth) Applications

The proliferation of wearable technologies, such as smartwatches, fitness trackers, and mobile health applications, offers new opportunities for continuous cardiac monitoring and personalized health management. Wearable devices equipped with built-in sensors can track vital signs, heart rate variability, and activity levels, providing valuable data for assessing cardiovascular health and detecting early signs of cardiac abnormalities. Integrating wearable technologies with cardiac monitoring devices and mHealth platforms enables seamless data transmission, real-time alerts, and personalized interventions, empowering individuals to take proactive steps towards improving their cardiac health.

CHALLENGE: Dearth of Skilled Professionals

In most countries, there is a shortage of physicians and healthcare professionals with the expertise and know-how to handle cardiac monitoring devices, such as ECG devices, new cardiac pacemakers, and defibrillators implanted in patients with heart rhythm ailments or congestive heart failure. According to a survey on the latest business conditions conducted by the National Association for Business Economics (NABE), 35% of participants reported a shortage of skilled professionals in the US. According to the Association of American Medical Colleges (AAMC), the US will face a shortage of approximately 124,000 physicians by 2034. This shortage of skilled professionals and physicians in healthcare will have an impact on the cardiac monitoring and cardiac rhythm management devices market

Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Ecosystem Analysis

An ecosystem analysis of the cardiac monitoring and cardiac rhythm management devices market involves examining the interconnected network of stakeholders, technologies, regulations, and market dynamics that shape the industry. It provides insights into the complex interplay between stakeholders, technologies, regulations, and market dynamics, guiding strategic decision-making and innovation within the industry.

 

Transvenous Implantable Cardioverter Defibrillators (T-ICDs in cardiac rhythm management devices market’s segment of the cardiac monitoring & cardiac rhythm management devices industry to witness the second highest shares during the forecast period.

Based on the Type, the global cardiac monitoring & cardiac rhythm management devices market is segmented into Transvenous Implantable Cardioverter Defibrillators (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators. Targeted Diseases Transvenous Implantable Cardioverter Defibrillators (T-ICDs), segment is expected to witness the second highest shares. The growth of this market is driven by due to its wide applications such as T-ICDs have been in clinical use for a longer period and have a more extensive clinical evidence base compared to S-ICDs, moreover, T-ICDs have demonstrated effectiveness in terminating life-threatening ventricular arrhythmias and preventing sudden cardiac death in various patient populations, including those with structural heart disease, coronary artery disease, and inherited arrhythmia syndromes.Morover, overall cost-effectiveness of T-ICDs may be favorable when considering long-term outcomes.

Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators segment of the cardiac monitoring & cardiac rhythm management devices industry to witness the highest shares during the forecast period.

Based on the Type, cardiac monitoring & cardiac rhythm management devices market is classified into Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators, Dual-Chamber Implantable Cardioverter Defibrillators, Single-Chamber Implantable Cardioverter Defibrillators. The Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators segment is forecasted to drive the highest shares of cardiac rhythm management devices Market. This is due to the BiV ICDs combine the functions of ICDs with cardiac resynchronization therapy (CRT), which is beneficial for patients with heart failure and ventricular dyssynchrony. Moreover, efficacy of BiV ICDs compared to single or dual-chamber ICDs in reducing mortality, hospitalizations, and heart failure symptoms in patients with heart failure and reduced ejection fraction. BiV ICDs have been shown to improve left ventricular function, reverse ventricular remodeling, and reduce the risk of arrhythmic events and sudden cardiac death.

NORTH AMERICA Region Holds the Largest Share of the Cardiac Monitoring & Cardiac Rhythm Management Devices Market.

Based on the region, the cardiac monitoring & cardiac rhythm management devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the cardiac monitoring & cardiac rhythm management devices market. Growth in the North American market is mainly driven by the factors such as Several leading medical device manufacturers based in North America, particularly in the United States, have a strong presence in the global healthcare market. These companies often have well-established distribution networks, brand recognition, and innovative product offerings that enable them to capture market share likewise, North American companies are often at the forefront of technological innovation in the healthcare industry. They invest heavily in research and development to develop advanced cardiac monitoring and rhythm management devices with cutting-edge features and functionalities, appealing to healthcare providers and patients.

 
 

Recent Developments of Cardiac Monitoring & Cardiac Rhythm Management Devices Market industry

  • In 2023, Abbott launched Asert-IQ, a Bluetooth-enabled insertable cardiac monitor for the long-term monitoring of heart rhythms. In 2023, Boston Scientific received FDA clearance and launched the next-generation LUX-Dx II/II+ ICM system for long-term monitoring of arrhythmias.
  • In 2021, Baxter International announced the acquisition of Hillrom. Baxter paid USD 156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of USD 10.5 billion (based on Hillrom share counts at closing).{deal size USD 12.5 billion}

Key Market Players

KEY PLAYERS IN THE Cardiac Monitoring & Cardiac Rhythm Management Devices Market INCLUDE

Want to explore hidden markets that can drive new revenue in Cardiac Monitoring & Cardiac Rhythm Management Devices Market?

Scope of the Report

Report Attribute Details
Market Revenue Size in 2024 $21.3 billion
Projected Revenue Size by 2029 $26.4 billion
Industry Growth Rate Poised to Grow at a CAGR of 4.3%
Market Driver Growing Geriatric Population and Subsequent Increase In CVD Prevalence
Market Opportunity Wearable Technologies and Mobile Health (MHealth) Applications

 

Key Questions Addressed by the Report

What is the projected market revenue value of the global cardiac monitoring & cardiac rhythm management devices market?
The global cardiac monitoring & cardiac rhythm management devices market boasts a total revenue value of $26.4 billion by 2029.
What is the estimated growth rate (CAGR) of the global cardiac monitoring & cardiac rhythm management devices market?
The global cardiac monitoring & cardiac rhythm management devices market has an estimated compound annual growth rate (CAGR) of 4.3% and a revenue size in the region of $21.3 billion in 2024.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
32
RESEARCH METHODOLOGY
37
EXECUTIVE SUMMARY
49
PREMIUM INSIGHTS
53
MARKET OVERVIEW
56
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing geriatric population and subsequent increase in CVD prevalence
    - Availability of reimbursement for CM & CRM devices
    - Rising awareness and prevention initiatives
    - Increasing investments, funds, and grants for research
    - Growing preference for wearable cardiac devices
    RESTRAINTS
    - High device costs
    - Adverse effects and associated complications
    OPPORTUNITIES
    - Measures to reduce infections caused by CIEDs
    - Untapped emerging markets
    CHALLENGES
    - Risk of associated cybersecurity vulnerabilities
    - Frequent product recalls
    - Stringent regulatory requirements delaying the approval of cardiac devices
    - Dearth of skilled professionals
  • 5.3 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 ECOSYSTEM/MARKET MAP
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - China
    - Japan
    - India
    LATIN AMERICA
    - Brazil
    - Mexico
    MIDDLE EAST
    AFRICA
  • 5.8 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
  • 5.9 TRADE ANALYSIS
  • 5.10 TECHNOLOGY ANALYSIS
    HOLTER MONITOR
    DEFIBRILLATORS
  • 5.11 PATENT ANALYSIS
  • 5.12 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
CARDIAC MONITORING DEVICES MARKET, BY TYPE
80
  • 6.1 INTRODUCTION
  • 6.2 ECG DEVICES
    RESTING ECG DEVICES
    - Low cost, ease of use, and simplicity to drive adoption
    STRESS ECG DEVICES
    - High device cost to affect adoption rate
    HOLTER MONITORS
    - Short duration of monitoring to restrain adoption
    EVENT MONITORS
    - Event monitors market, by type
    - Event monitors market, by technology
    SMART ECG MONITORS
    - Lack of data security to hinder market growth
  • 6.3 MCT DEVICES
    INCREASING DEMAND FOR CARDIAC MONITORING SOLUTIONS IN HOME CARE SETTINGS TO PROPEL MARKET GROWTH
  • 6.4 COM DEVICES
    RISING NUMBER OF CARDIAC SURGERIES TO DRIVE DEMAND FOR COM DEVICES
CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE
93
  • 7.1 INTRODUCTION
  • 7.2 DEFIBRILLATORS
    IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    - Transvenous ICDs
    - Subcutaneous ICDs
    EXTERNAL DEFIBRILLATORS
    - Automated external defibrillators
    - Manual external defibrillators
    - Wearable cardioverter defibrillators
  • 7.3 PACEMAKERS
    PACEMAKERS MARKET, BY IMPLANTABILITY
    - Implantable pacemakers
    - External pacemakers
    PACEMAKERS MARKET, BY TYPE
    - Biventricular/CRT-Ps
    - Dual-chamber pacemakers
    - Single-chamber pacemakers
CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE
111
  • 8.1 INTRODUCTION
  • 8.2 INVASIVE PROCEDURES
    GROWING NUMBER OF CARDIAC PROCEDURES TO DRIVE MARKET GROWTH
  • 8.3 NON-INVASIVE PROCEDURES
    GROWING PREVALENCE OF LIFESTYLE AND GENETIC DISEASES TO PROPEL ADOPTION
CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION
114
  • 9.1 INTRODUCTION
  • 9.2 ARRHYTHMIAS
    GROWING NUMBER OF ATRIAL FIBRILLATION CASES TO DRIVE MARKET
  • 9.3 MYOCARDIAL INFARCTION
    RISING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
  • 9.4 HEART FAILURE
    GROWING AGING POPULATION TO DRIVE PREVALENCE OF HEART FAILURE
  • 9.5 OTHER APPLICATIONS
CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER
119
  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
    RISING NUMBER OF CARDIAC IMPLANT PROCEDURES TO DRIVE MARKET
  • 10.3 CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS
    GROWING FOCUS ON AMBULATORY CARE IN US TO PROPEL DEVICE ADOPTION
  • 10.4 OTHER END USERS
CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION
123
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to hold largest market share in North America
    CANADA
    - Growing funding for research to drive market
  • 11.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Increasing healthcare expenditure to drive market growth
    FRANCE
    - Rising prevalence of heart failure to boost adoption of CRT devices
    UK
    - Rising demand for home-based cardiac monitoring devices to support market growth
    ITALY
    - Increasing incidence of atrial fibrillation to drive market
    SPAIN
    - Rising awareness and growing device adoption to support market growth
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    JAPAN
    - High healthcare expenditure and favorable reimbursement & insurance policies to support market growth
    CHINA
    - Rising prevalence of CVDs and government support for infrastructural improvement to drive market
    INDIA
    - Increasing incidence of CVD to propel market growth
    REST OF ASIA PACIFIC
  • 11.5 REST OF THE WORLD
    REST OF THE WORLD: RECESSION IMPACT
    LATIN AMERICA
    - Rising patient population and growing disease incidence to support market growth
    MIDDLE EAST & AFRICA
    - Prominence of local players and healthcare infrastructural improvements to support growth
    GCC COUNTRIES
    - Increasing awareness and government initiatives to favor market growth
COMPETITIVE LANDSCAPE
233
  • 12.1 OVERVIEW
  • 12.2 KEY STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 12.3 MARKET SHARE ANALYSIS
  • 12.4 REVENUE SHARE ANALYSIS
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT
  • 12.6 COMPANY EVALUATION MATRIX: START-UP/SME PLAYERS
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
  • 12.7 VALUATION AND FINANCIAL METRICS OF CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICE VENDORS
  • 12.8 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
  • 12.9 BRAND/PRODUCT COMPARISON
COMPANY PROFILES
248
  • 13.1 KEY PLAYERS
    ABBOTT LABORATORIES
    - Business overview
    - Products offered
    - Recent developments
    - MNM view
    MEDTRONIC
    - Business overview
    - Products offered
    - MnM view
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    GE HEALTHCARE
    - Business overview
    - Products offered.
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Products offered
    - Recent developments
    ASAHI KASEI CORPORATION
    - Business overview
    - Products offered
    MICROPORT SCIENTIFIC CORPORATION
    - Business overview
    - Products offered.
    BAXTER
    - Business overview
    - Products offered
    - Recent developments
    NIHON KOHDEN CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    BIOTRONIK
    - Business overview
    - Products offered
    SCHILLER
    - Business overview
    - Products offered
    ACS DIAGNOSTICS
    - Business overview
    - Products offered
    BPL MEDICAL TECHNOLOGIES
    - Business overview
    - Products offered
    BTL
    - Business overview
    - Products offered
    SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    - Business overview
    - Products offered
  • 13.2 OTHER PLAYERS
    OSYPKA AG
    ALIVECOR, INC.
    AMIITALIA
    BEXEN CARDIO
    NARANG MEDICAL LIMITED
    PRIMEDIC
    PROGETTI
    INNOMED MEDICAL INC.
    LUMED SRL
    NASIFF ASSOCIATES INC.
APPENDIX
287
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 RISK ASSESSMENT: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
  • TABLE 2 CPT CODES FOR CM & CRM DEVICES, 2020
  • TABLE 3 POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT DEVICES
  • TABLE 4 KEY PRODUCT RECALLS
  • TABLE 5 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 6 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET: ROLE IN ECOSYSTEM
  • TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 AVERAGE SELLING PRICE OF HOLTER ECG MONITORS
  • TABLE 13 AVERAGE SELLING PRICE OF DEFIBRILLATORS
  • TABLE 14 IMPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 15 EXPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 16 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: LIST OF CONFERENCES AND EVENTS
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS (%)
  • TABLE 18 KEY BUYING CRITERIA FOR TOP TWO END USERS
  • TABLE 19 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 20 ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 21 ECG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 22 RESTING ECG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 23 STRESS ECG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 24 HOLTER MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 25 EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 26 EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 27 LOOP MEMORY MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 28 PATCH RECORDER EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 29 SYMPTOM EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 30 IMPLANTED LOOP RECORDERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 31 EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 32 PATIENT-ACTIVATED EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 33 AUTO-DETECT EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 34 INDICATIVE LIST OF SMART ECG MONITORS
  • TABLE 35 SMART ECG MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 36 MCT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 37 TYPES OF COM DEVICES
  • TABLE 38 COM DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 39 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 40 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2023–2029 (UNITS)
  • TABLE 41 DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 42 DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 43 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 44 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 45 TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 46 TRANSVENOUS ICDS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 47 BIVENTRICULAR ICDS/CRT-DS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 48 DUAL-CHAMBER ICDS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 SINGLE-CHAMBER ICDS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 SUBCUTANEOUS ICDS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 51 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 52 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 53 INDICATIVE LIST OF AEDS THAT HAVE RECEIVED US FDA PRE-MARKET APPROVAL (2018–2022)
  • TABLE 54 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 55 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 59 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 PACEMAKERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 61 PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 62 IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 63 EXTERNAL PACEMAKERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 64 PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 65 BIVENTRICULAR/CRT-PS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 66 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 67 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 68 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 69 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR INVASIVE PROCEDURES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 70 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR NON-INVASIVE PROCEDURES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 71 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 72 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR ARRHYTHMIAS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR MYOCARDIAL INFARCTION, 2022–2029 (USD MILLION)
  • TABLE 74 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HEART FAILURE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 75 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 76 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 77 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 78 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 79 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 80 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 81 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 82 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 89 NORTH AMERICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 96 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 98 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 99 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 101 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 102 US: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 103 US: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 104 US: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 105 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 US: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 US: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 109 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 US: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 112 US: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 113 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 114 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 115 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 116 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 CANADA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 118 CANADA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 119 CANADA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 120 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 123 CANADA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 124 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 125 CANADA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 127 CANADA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 129 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 130 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 131 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 135 EUROPE: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 136 EUROPE: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 137 EUROPE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 138 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 139 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 EUROPE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 142 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 145 EUROPE: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 146 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 147 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 148 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 149 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 150 GERMANY: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 GERMANY: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 GERMANY: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 153 GERMANY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 GERMANY: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 GERMANY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 160 GERMANY: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 162 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 163 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 164 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 FRANCE: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 FRANCE: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 FRANCE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 168 FRANCE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 170 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 171 FRANCE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 FRANCE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 175 FRANCE: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 176 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 177 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 178 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 179 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 180 UK: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 181 UK: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 UK: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 183 UK: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 184 UK: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 185 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 186 UK: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 188 UK: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 189 UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 190 UK: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 191 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 192 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 193 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 194 ITALY: NUMBER OF ELDERLY CITIZENS WITH ATRIAL FIBRILLATION (THOUSANDS)
  • TABLE 195 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 ITALY: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 ITALY: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 198 ITALY: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 199 ITALY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 200 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 202 ITALY: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 204 ITALY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 ITALY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 206 ITALY: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 208 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 209 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 210 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 SPAIN: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 212 SPAIN: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 213 SPAIN: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 214 SPAIN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 215 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 216 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 217 SPAIN: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 218 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 219 SPAIN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 SPAIN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 221 SPAIN: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 222 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 223 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 224 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 225 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2029 VS. 2050
  • TABLE 226 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 227 REST OF EUROPE: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 228 REST OF EUROPE: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 229 REST OF EUROPE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 230 REST OF EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 REST OF EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 233 REST OF EUROPE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 234 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 235 REST OF EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 236 REST OF EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 237 REST OF EUROPE: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 238 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 239 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 240 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 244 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 245 ASIA PACIFIC: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 ASIA PACIFIC: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 252 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 253 ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 254 ASIA PACIFIC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 255 ASIA PACIFIC: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 257 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 258 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 259 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 JAPAN: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 JAPAN: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 262 JAPAN: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 263 JAPAN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 264 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 265 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 JAPAN: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 JAPAN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 270 JAPAN: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 272 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 273 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 274 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 CHINA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 CHINA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 277 CHINA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 278 CHINA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 279 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 280 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 281 CHINA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 282 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 283 CHINA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 285 CHINA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 287 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 288 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 289 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 290 INDIA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 291 INDIA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 INDIA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 293 INDIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 294 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 295 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 296 INDIA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 297 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 298 INDIA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 299 INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 300 INDIA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 301 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 302 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 303 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 304 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 305 REST OF ASIA PACIFIC: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 306 REST OF ASIA PACIFIC: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 307 REST OF ASIA PACIFIC: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 308 REST OF ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 309 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 310 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 311 REST OF ASIA PACIFIC: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 312 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 313 REST OF ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 314 REST OF ASIA PACIFIC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 315 REST OF ASIA PACIFIC: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 316 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 317 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 318 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 319 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 320 REST OF THE WORLD: CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 321 REST OF THE WORLD: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 322 REST OF THE WORLD: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 323 REST OF THE WORLD: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 324 REST OF THE WORLD: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 325 REST OF THE WORLD: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 326 REST OF THE WORLD: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 327 REST OF THE WORLD: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 328 REST OF THE WORLD: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 REST OF THE WORLD: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 330 REST OF THE WORLD: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 331 REST OF THE WORLD: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 332 REST OF THE WORLD: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 333 REST OF THE WORLD: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 334 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 335 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 336 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 337 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 338 LATIN AMERICA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 339 LATIN AMERICA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 340 LATIN AMERICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 341 LATIN AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 342 LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 343 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 344 LATIN AMERICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 345 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 346 LATIN AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 347 LATIN AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 348 LATIN AMERICA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 349 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 350 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 351 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 352 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 353 MIDDLE EAST & AFRICA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 354 MIDDLE EAST & AFRICA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 355 MIDDLE EAST & AFRICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 356 MIDDLE EAST & AFRICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 357 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 358 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 359 MIDDLE EAST & AFRICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 360 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 361 MIDDLE EAST & AFRICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 362 MIDDLE EAST & AFRICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 363 MIDDLE EAST & AFRICA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 364 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 365 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 366 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 367 GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 368 GCC COUNTRIES: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 369 GCC COUNTRIES: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 370 GCC COUNTRIES: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 371 GCC COUNTRIES: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 372 GCC COUNTRIES: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 373 GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 374 GCC COUNTRIES: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 375 GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 376 GCC COUNTRIES: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 377 GCC COUNTRIES: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
  • TABLE 378 GCC COUNTRIES: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 379 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 380 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 381 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 382 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CARDIAC MONITORING DEVICES & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
  • TABLE 383 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 384 COMPANY FOOTPRINT
  • TABLE 385 PRODUCT FOOTPRINT
  • TABLE 386 REGIONAL FOOTPRINT
  • TABLE 387 DETAILED LIST OF KEY START-UPS/SMES IN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
  • TABLE 388 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2024
  • TABLE 389 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: DEALS, JANUARY 2021–APRIL 2024
  • TABLE 390 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 391 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 392 ABBOTT LABORATORIES: PRODUCT LAUNCHES (JANUARY 2021–APRIL 2024)
  • TABLE 393 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 394 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 395 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 396 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 397 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS (JANUARY 2021–APRIL 2024)
  • TABLE 398 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 399 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 400 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 401 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 402 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES (JANUARY 2021–APRIL 2024)
  • TABLE 403 ASAHI KASEI CORPORATION: COMPANY OVERVIEW
  • TABLE 404 ASAHI KASEI CORPORATION: PRODUCTS OFFERED
  • TABLE 405 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 406 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 407 BAXTER: COMPANY OVERVIEW
  • TABLE 408 BAXTER: PRODUCTS OFFERED
  • TABLE 409 BAXTER: DEALS (JANUARY 2021–APRIL 2024)
  • TABLE 410 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 411 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
  • TABLE 412 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES (JANUARY 2021–APRIL 2024)
  • TABLE 413 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 414 BIOTRONIK: PRODUCTS OFFERED
  • TABLE 415 SCHILLER: COMPANY OVERVIEW
  • TABLE 416 SCHILLER: PRODUCTS OFFERED
  • TABLE 417 ACS DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 418 ACS DIAGNOSTICS: PRODUCTS OFFERED
  • TABLE 419 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 420 BPL MEDICAL TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 421 BTL: COMPANY OVERVIEW
  • TABLE 422 BTL: PRODUCTS OFFERED
  • TABLE 423 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 424 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 7 TOP-DOWN APPROACH
  • FIGURE 8 MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 9 ASSUMPTIONS FOR RESEARCH
  • FIGURE 10 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 GROWING PREVALENCE OF GENETIC DISORDERS TO DRIVE MARKET
  • FIGURE 17 RESTING ECG DEVICES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 18 US AND INVASIVE PROCEDURES TO DOMINATE NORTH AMERICAN MARKET IN 2024
  • FIGURE 19 ASIAN COUNTRIES TO REGISTER HIGHER GROWTH FROM 2024 TO 2029
  • FIGURE 20 CM & CRM DEVICES MARKET: DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
  • FIGURE 21 HEART AND CIRCULATORY DISEASE PREVALENCE: GLOBAL STATISTICS (2021)
  • FIGURE 22 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: ECOSYSTEM
  • FIGURE 23 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET: KEY PLAYERS
  • FIGURE 24 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
  • FIGURE 25 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES
  • FIGURE 26 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: TOP 10 COMPANIES (APPLICATIONS/OWNERS)
  • FIGURE 27 REVENUE SHIFT IN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
  • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS
  • FIGURE 29 KEY BUYING CRITERIA FOR TOP TWO END USERS
  • FIGURE 30 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 31 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 32 REVENUE SHARE ANALYSIS OF KEY PLAYERS
  • FIGURE 33 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 34 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 35 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (START-UP/SME PLAYERS), 2023
  • FIGURE 36 EV/EBITDA OF KEY VENDORS
  • FIGURE 37 EV/REV OF KEY VENDORS
  • FIGURE 38 BETA (5 YEARS) OF KEY VENDORS
  • FIGURE 39 1-YEAR PRICE TOTAL RETURN OF KEY VENDORS
  • FIGURE 40 ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 42 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 43 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 45 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
  • FIGURE 46 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 47 BAXTER: COMPANY SNAPSHOT
  • FIGURE 48 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

The study involved four major activities in estimating the current size of the cardiac monitoring & cardiac rhythm management devices Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Cardiologist, Surgeons, Cardiac consultant) and supply sides (cardiac monitoring & cardiac rhythm management devices providers and distributors).

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Cardiac  Monitoring & Cardiac Rhythm Management Devices Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac monitoring & cardiac rhythm management devices Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Cardiac  Monitoring & Cardiac Rhythm Management Devices Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Cardiac  Monitoring & Cardiac Rhythm Management Devices Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cardiac monitoring & cardiac rhythm management devices industry.

MARKET DEFINITION

Cardiac monitoring refers to the continuous monitoring of heart activities by cardiac monitoring devices such as electrocardiograms, recording devices, and visual/audible recorders. These devices are used to identify or rule out a heart rhythm disorder and determine the right course of treatment.

Cardiac rhythm management devices include implantable devices (defibrillators and pacemakers), leads, and external devices to treat and manage arrhythmia-related diseases. The major end users of implantable pacemakers and defibrillators are hospitals, cardiac centers, clinics, and ambulatory surgery centers.

MARKET STAKEHOLDERS

  • Government and academic institutes
  • Research laboratories, diagnostic centers, and research institutes.
  • Cardiac monitoring and cardiac rhythm management device manufacturers
  • Suppliers and distributors
  • Monitoring service providers
  • Healthcare service providers
  • Physicians
  • Diagnostic centers
  • Health insurance players
  • Research and consulting firms.

Report Objectives

  • To define, describe, and forecast the global cardiac monitoring & cardiac rhythm management devices Market based on Type, Application, Procedure, End User, and Region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)   
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the cardiac monitoring & cardiac rhythm management devices Market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
  • Geographic Analysis:  Further breakdown of the European cardiac monitoring & cardiac rhythm management devices Market into specific countries.

Previous Versions of this Report

Cardiac Monitoring & Cardiac Rhythm Management Devices Market, Product, CM (ECG (Holter Monitor), ILR, Event Monitor)), CRM ((Defibrillator (ICD) External (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User - Global Forecast to 2025

Report Code MD 1038
Published in Sep, 2020, By MarketsandMarkets™

Cardiac Monitoring & Cardiac Rhythm Management Devices Market – CM (ECG, ILR, Event Monitors, MCT), CRM (Defibrillator [ICD {CRT D}, External Defibrillators {AED}], Pacemaker [CRT P, Dual Chamber Pacemaker]), End User (Hospitals) - Global Forecast to 2024

Report Code MD 1038
Published in Oct, 2019, By MarketsandMarkets™

Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product (ECG, Cardiac Output Monitoring, ILR), CRM [ICDs, External Defibrillator, Pacemaker (Dual Chamber Pacemaker)], End User (Home and Ambulatory, Hospital) - Global Forecast to 2022

Report Code MD 1038
Published in Apr, 2018, By MarketsandMarkets™

Cardiac Monitoring & Cardiac Rhythm Management Devices Market CM [ECG (Resting, Stress, Holter Monitor), COM Devices, Implantable Loop Recorders, Event Monitors], CRM (Defibrillators (ICDs, External), Pacemakers, CRT-D, CRT-P) - Global Forecast to 2021

Report Code MD 1038
Published in Nov, 2016, By MarketsandMarkets™

Cardiac Monitoring & Cardiac Rhythm Management Market ECG, Implantable Loop Recorder, Manual Event Monitor, Cardiac Output Monitoring, Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P - Global Forecast to 2020

Report Code PH 3575
Published in Jul, 2015, By MarketsandMarkets™

Cardiac Monitoring & Cardiac Rhythm Management Market ECG, Implantable Loop Recorder, Manual Event Monitor, Cardiac Output Monitoring, Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P - Global Forecast to 2020

Report Code PH 3575
Published in Jan, 2011, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Cardiac Monitoring & Cardiac Rhythm Management Devices Market

DMCA.com Protection Status